584 results
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
17 Jun 24
Departure of Directors or Certain Officers
4:02pm
transactions, including stock splits, recapitalizations and mergers, transferability of awards and tax withholding requirements. The Restated Plan may
8-K
EX-99.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
7 May 24
Ligand Reports First Quarter 2024 Financial Results
4:03pm
companies, excess tax benefit from share-based compensation, income tax effect of adjusted reconciling items and others that are listed in the itemized … in public companies, share-based compensation expense and the effects of any discrete income tax items. Management has excluded the effects
8-K
EX-99.1
5wk 4nsgymz2v
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
8-K/A
EX-99.1
3kup2 614h3c4
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K/A
ti48bxl
9 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
9:48pm
8-K
EX-99.1
at4z54sw jnv266sutbx
8 Nov 23
Ligand Reports Third Quarter 2023 Financial Results
4:08pm
8-K
EX-10.1
18it0819h9bmam
17 Oct 23
Entry into a Material Definitive Agreement
7:24pm
8-K
EX-99.1
hmaeh9gb ngsep4pbdc
8 Aug 23
Ligand Reports Second Quarter 2023 Financial Results
4:02pm
8-K
EX-99.1
yhusz71hl
4 May 23
Ligand Reports First Quarter 2023 Financial Results
4:06pm